eHealth, Inc., doing business as eHealthInsurance, is a publicly traded online marketplace for health insurance, organized in Delaware and based in Santa Clara, California. The company primarily provides plans related to Medicare such as prescription drug plans, Medigap, and Medicare Advantage plans. The company also sells individual plans, competing with health insurance marketplaces. The company sells plans in all 50 U.S. states and the District of Columbia from 170 health insurance carriers. Its large staff of licensed agents assist consumers with little or no computer experience with their online enrollments.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| EHTH | eHealth, Inc. | 2026-03-03 06:16:47 | 1.43 | 0.19 | 15.32 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EHTH | 0001333493 | eHealth, Inc. | US28238P1093 | 5299003O8Y5OKXUZQ421 | 562357876 | Nasdaq | 6411 | Insurance Agents, Brokers & Service | 1231 | DE | 9190 PRIORITY WAY WEST DR., SUITE 110 | INDIANAPOLIS | IN | 46240 | UNITED STATES | US | 737-248-2340 | 9190 PRIORITY WAY WEST DR., SUITE 110, INDIANAPOLIS, IN, 46240 | 9190 PRIORITY WAY WEST DR., SUITE 110, INDIANAPOLIS, IN, 46240 | — | — | 1997 | Fran Soistman | 1,079 | https://eHealthInsurance.com/ | 127,700,000 | 43,225,000 | 30,764,785 | eHealth, Inc., doing business as eHealthInsurance, is a publicly traded online marketplace for health insurance, organized in Delaware and based in Santa Clara, California. The company primarily provides plans related to Medicare such as prescription drug plans, Medigap, and Medicare Advantage plans. The company also sells individual plans, competing with health insurance marketplaces. The company sells plans in all 50 U.S. states and the District of Columbia from 170 health insurance carriers. Its large staff of licensed agents assist consumers with little or no computer experience with their online enrollments. | 2026-02-26 20:37:54 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 126,200,000 | -1,500,000 | -1.1746 | 31,073,002 | 1,130,398 | 3.7752 |
| 2024 | 127,700,000 | -93,200,000 | -42.191 | 29,942,604 | 1,004,095 | 3.4698 |
| 2023 | 220,900,000 | -31,100,000 | -12.3413 | 28,938,509 | 1,324,834 | 4.7977 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Gavin G. Galimi | Corporate Secretary, General Counsel, Senior Vice President | 2024 | 420,865 | 0 | 615,850 | 375,941 | 10,694 | 1,423,350 |
| Michelle M. Barbeau | Chief Revenue Officer | 2024 | 433,308 | 0 | 995,350 | 483,750 | 11,284 | 1,923,692 |
| Francis S. Soistman | Chief Executive Officer | 2024 | 755,769 | 0 | 1,305,000 | 1,350,000 | 17,434 | 3,428,203 |
| Gavin G. Galimi | Corporate Secretary, General Counsel, Senior Vice President | 2023 | 385,769 | 0 | 460,000 | 335,495 | 10,147 | 1,191,411 |
| John J. Stelben | Chief Financial Officer, Senior Vice President | 2023 | 500,000 | 0 | 2,413,750 | 562,500 | 13,464 | 3,489,714 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 1,665 |
| 2024 | 1,773 |
| 2023 | 1,903 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 554,008,000 | 532,410,000 | 452,871,000 |
| Cost Of Revenue | 1,333,000 | 1,794,000 | 1,771,000 |
| Gross Profit | 240,768,000 | 208,458,000 | — |
| Research And Development Expenses | 13,800,000 | 12,400,000 | 13,700,000 |
| General And Administrative Expenses | 89,555,000 | 89,765,000 | 86,761,000 |
| Operating Expenses | 487,519,000 | 508,839,000 | 481,945,000 |
| Operating Income | 66,489,000 | 23,571,000 | -29,074,000 |
| Net Income | 40,044,000 | 10,057,000 | -28,214,000 |
| Earnings Per Share Basic | -0.34 | -1.19 | -2.37 |
| Earnings Per Share Diluted | -0.34 | -1.19 | -2.37 |
| Weighted Average Shares Outstanding Basic | 30,484,000 | 29,335,000 | 28,016,000 |
| Weighted Average Shares Outstanding Diluted | 30,484,000 | 29,335,000 | 28,016,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 73,725,000 | 39,197,000 | 115,722,000 |
| Marketable Securities Current | 3,495,000 | 43,043,000 | 5,930,000 |
| Accounts Receivable | 7,688,000 | 16,807,000 | 3,993,000 |
| Inventories | — | — | — |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 1,104,000 | 2,405,000 | 1,808,000 |
| Total Assets Current | 334,352,000 | 354,475,000 | 382,352,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 4,531,000 | 4,437,000 | 4,864,000 |
| Other Assets Non Current | 25,452,000 | 23,819,000 | 26,758,000 |
| Total Assets Non Current | 28,060,000 | 26,332,000 | 29,700,000 |
| Total Assets | 1,262,468,000 | 1,155,425,000 | 1,113,345,000 |
| Accounts Payable | 28,323,000 | 23,448,000 | 7,197,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | — | — | — |
| Other Liabilities Current | 6,207,000 | 4,331,000 | 3,131,000 |
| Total Liabilities Current | 99,070,000 | 96,011,000 | 78,538,000 |
| Long Term Debt | 112,954,000 | 68,458,000 | 67,754,000 |
| Other Liabilities Non Current | 5,519,000 | 5,418,000 | 4,949,000 |
| Total Liabilities Non Current | 189,746,000 | 133,477,000 | 130,723,000 |
| Total Liabilities | 288,816,000 | 229,488,000 | 209,261,000 |
| Common Stock | 44,000 | 43,000 | 41,000 |
| Retained Earnings | 30,116,000 | 15,246,000 | 7,284,000 |
| Accumulated Other Comprehensive Income | -62,000 | -234,000 | -82,000 |
| Total Shareholders Equity | 591,595,000 | 588,428,000 | 606,031,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 1,881,000 | 1,983,000 | 19,916,000 |
| Share Based Compensation Expense | 15,043,000 | 19,881,000 | 23,213,000 |
| Other Non Cash Income Expense | -247,000 | -429,000 | -701,000 |
| Change In Accounts Receivable | -9,120,000 | 12,814,000 | 1,361,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 5,009,000 | 16,173,000 | 487,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | -25,345,000 | -18,366,000 | -6,692,000 |
| Purchases Of Marketable Securities | 74,010,000 | 96,985,000 | 54,514,000 |
| Sales Of Marketable Securities | 114,750,000 | 61,420,000 | 49,400,000 |
| Acquisition Of Property Plant And Equipment | 2,250,000 | 2,094,000 | 2,086,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | 25,432,000 | -48,421,000 | -15,893,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 5,900,000 | 5,600,000 | 3,500,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | -2,439,000 | -3,413,000 | -3,330,000 |
| Issuance Of Long Term Debt | 122,188,000 | — | 0 |
| Repayment Of Long Term Debt | 70,732,000 | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | 34,288,000 | -9,674,000 | -6,224,000 |
| Change In Cash | 34,528,000 | -76,525,000 | -28,828,000 |
| Cash At End Of Period | 73,725,000 | 39,197,000 | 115,722,000 |
| Income Taxes Paid | 390,000 | 441,000 | 327,000 |
| Interest Paid | 8,922,000 | 9,232,000 | 9,054,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -0.34 | -1.19 | -2.37 |
| Price To Earnings Ratio | -13.5294 | -7.8992 | -3.6793 |
| Earnings Growth Rate | -71.4286 | -49.789 | -45.6422 |
| Price Earnings To Growth Ratio | 0.1894 | 0.1587 | 0.0806 |
| Book Value Per Share | 31.9398 | 31.5642 | 32.2703 |
| Price To Book Ratio | 0.144 | 0.2978 | 0.2702 |
| Ebitda | 53,076,000 | 23,640,000 | 3,003,000 |
| Enterprise Value | 179,455,400 | 305,010,000 | 196,331,520 |
| Dividend Yield | 0.0421 | 0.0203 | 0.0143 |
| Dividend Payout Ratio | 0.1473 | 0.5568 | -0.1241 |
| Debt To Equity Ratio | 0.1909 | 0.1163 | 0.1118 |
| Capital Expenditures | 1,975,000 | 1,556,000 | 19,279,000 |
| Free Cash Flow | -27,320,000 | -19,922,000 | -25,971,000 |
| Return On Equity | 0.0677 | 0.0171 | -0.0466 |
| One Year Beta | 1.6417 | 0.9005 | 2.1701 |
| Three Year Beta | 1.6056 | 1.5089 | 1.6258 |
| Five Year Beta | 1.5521 | 1.2467 | 1.3198 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| DUKE DERRICK A | Director, Chief Executive Officer | 2026-02-27 | 187,969 | A | 487,969 |
| Dolan John Joseph | Chief Financial Officer | 2026-02-10 | 1,738 | D | 183,755 |
| Galimi Gavin G. | SVP, General Counsel & Secr. | 2026-01-10 | 966 | D | 230,742 |
| Dolan John Joseph | Chief Financial Officer | 2026-01-10 | 539 | D | 185,493 |
| Barbeau Michelle Marie | Chief Revenue Officer | 2026-01-10 | 379 | D | 248,046 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Kera Capital Partners, Inc. | 2025-12-31 | 97,615 | 34,493 | 2.83 |
| Virtu Financial LLC | 2025-12-31 | 155,000 | 33,678 | 4.6024 |
| Invesco Ltd. | 2025-12-31 | 297,942 | 64,770 | 4.6 |
| Corient Private Wealth LLC | 2025-12-31 | 304,113 | 66,232 | 4.5916 |
| MACKENZIE FINANCIAL CORP | 2025-12-31 | 2,003,027 | 442,065 | 4.5311 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| RYDEX SERIES FUNDS | 2025-12-31 | Class C | RYCMX | 40 | 184 | 0.0022 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class A | RYAKX | 40 | 184 | 0.0022 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class H | RYMKX | 40 | 184 | 0.0022 |
| RYDEX DYNAMIC FUNDS | 2025-12-31 | H-Class Shares | RYRSX | 147 | 676.2 | 0.0012 |
| RYDEX DYNAMIC FUNDS | 2025-12-31 | C-Class Shares | RYRLX | 147 | 676.2 | 0.0012 |